MedTrace Logo

Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia

NCT05389176 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2022-05-25

No results posted yet for this study

Summary

A sigle-center, randomized controlled trial will be do to investigate the effects of esomol on heart rate, clinical parameters, mortality, and safety in septic shock patients with tachycardia at different stages, compared with patients who received conventional therapy.

Conditions

  • Septic Shock
  • Tachycardia

Interventions

DRUG

Esmolol

a continuous esmolol infusion titrated to maintain heart rate between 70/min and 100/min

Sponsors & Collaborators

  • Chinese Medical Association

    lead NETWORK

Principal Investigators

  • Wenkui Yu, MD · The Affliated Drum Tower Hospital, Medical School of Nanjing University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-03-31
Completion
2024-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389176 on ClinicalTrials.gov